Coexistence of psoriatic arthritis and collagenous colitis with inflammatory nervous system disease.
Dhouha
D
Azzouz
Amina
A
Gargouri
Wafa
W
Hamdi
Hela
H
Kchir
Yosr
Y
Hizem
Raoudha
R
Tekaya
Mouna
M
Ben Djebara
Riadh
R
Gouider
Mohamed Montacer
MM
Kchir
D000287:Administration, Topical; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D001921:Brain / Q000473:pathology; D046729:Colitis, Collagenous / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003711:Demyelinating Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009902:Optic Neuritis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D012460:Sulfasalazine / Q000627:therapeutic use; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D012460:Sulfasalazine